Market Snapshot

BSE Sensex: 77100.47 0.14%
BSE 500: 36133.32 -0.05%
BSE 200: 11237.3 0.04%
BSE 100: 25618.46 0.14%
BSE BANKEX: 65599.62 0.03%
BSE IT: 26650.91 -0.88%
Nifty 50: 24056 0.14%
Nifty 500: 23113.7 -0.05%
Nifty 200: 13891.25 0.01%
Nifty 100: 25114.1 0.15%
Nifty Midcap 100: 61795.5 -0.55%
Nifty Small 100: 18790.35 -0.47%
Nifty IT: 27330.85 -0.86%
Nifty PSU Bank: 8636.1 0.09%

News:

Refex Industries bags Rs 21-cr...
BEML bags export contract for ...
Aether Industries commences co...
Dr Reddy?s Labs receives seven...
ONGC appoints Anupam Agarwal a...

Pharmaids Pharmaceuticals Ltd Share Price – BSE
Pharmaceuticals, Small Cap

Invest

25 Jun 2026 | 03:59 PM

37.88

3.57 (10.41%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

-33.81%

Return (1Y)

Underperformed BSE Sensex by 26.98%
More Volatile

3.34%

Standard Deviation (1Y)

Higher than BSE Sensex by 2.5%
Not so consistent

4/12

Months

underperformed BSE Sensex
AxisDirect View

No View

52 Week High-Low

News & Announcements

Pharmaids Pharmaceuticals to conduct board meeting
34 days ago

Pharmaids Pharmaceuticals to conduct board meeting

23 - May - 2026 12:00 | 34 days ago

Pharmaids Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 May 2026.
Pharmaids Pharmaceuticals announces divestment of step-down subsidiary
90 days ago

Pharmaids Pharmaceuticals announces divestment of step-down subsidiary

28 - Mar - 2026 12:00 | 90 days ago

Pharmaids Pharmaceuticals announced the disinvestment/sale of shareholding in Siri Labvivo Diet (the company's step-down subsidiary) by Adita Bio Sys (the company's material subsidiary).
Consequent to the completion of the above transaction, Siri Labvivo Diet has ceased to be a subsidiary of Adita Bio Sys and accordingly, has also ceased to be a step-down subsidiary of the Company with effect from 27 March 2026.
Powered by Capital Market - Live News
Pharmaids Pharmaceuticals reports consolidated net loss of Rs 2.48 crore in the December 2025 quarter
133 days ago

Pharmaids Pharmaceuticals reports consolidated net loss of Rs 2.48 crore in the December 2025 quarter

13 - Feb - 2026 12:00 | 133 days ago

Net Loss of Pharmaids Pharmaceuticals reported to Rs 2.48 crore in the quarter ended December 2025 as against net loss of Rs 1.93 crore during the previous quarter ended December 2024. Sales rose 15.29% to Rs 5.43 crore in the quarter ended December 2025 as against Rs 4.71 crore during the previous quarter ended December 2024.

Particulars Quarter Ended
Dec. 2025 Dec. 2024 % Var.

Sales 5.43 4.71 15

OPM % -46.22 -61.36 -

PBDT -3.15 -3.36 6

PBT -3.62 -4.00 10

NP -2.48 -1.93 -28

Powered by Capital Market - Live News
Pharmaids Pharmaceuticals schedules board meeting
137 days ago

Pharmaids Pharmaceuticals schedules board meeting

09 - Feb - 2026 12:00 | 137 days ago

Pharmaids Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 February 2026.
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

Promoter shareholding in Pharmaids Pharmaceuticals Ltd has increased by 532.17% since past 1 Year
Pharmaids Pharmaceuticals Ltd has the Lowesr P/E ratio according to FY 202603 data among stocks in Pharmaceuticals Sector
Pharmaids Pharmaceuticals Ltd has the Lowesr P/B ratio according to FY 202603 data among stocks in Pharmaceuticals Sector

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	5.43	4.71	15
OPM %	-46.22	-61.36	-
PBDT	-3.15	-3.36	6
PBT	-3.62	-4.00	10
NP	-2.48	-1.93	-28

General Notifications

My Notifications

Research Notifications

Pharmaids Pharmaceuticals Ltd Share Price – BSE Pharmaceuticals, Small Cap

37.88 3.57 (10.41%)

News & Announcements

Price vs Volume

Stock Trivia

Pharmaids Pharmaceuticals Ltd Share Price – BSE
Pharmaceuticals, Small Cap

37.88

3.57 (10.41%)